Waste from marble quarry used to 3D print architectural elements Professional Additive Manufacturing

by Architecture

According to Digital Building Technologies, researchers at the Swiss Federal Institute of Technology Zurich (ETH) and the University of Applied Sciences and Arts of Southern Switzerland (SUPSI) have developed a 3D printer designed to transform large quantities of stone waste from quarries into customizable architectural elements. The stone waste, or rock flour, in places like Ticino, can constitute up to 40% of total production. The printer was demonstrated in a case study, where it fabricated an optimized floor system using the byproduct of a marble quarry in Ticino.

Stratasys and CollPlant joint development addresses .6B bioprinting market opportunity

Stratasys and CollPlant joint development addresses $2.6B bioprinting market opportunity

by Medical

Stratasys and CollPlant have announced plans to “transform healthcare with industrial scale bioprinting of tissues and organs.” To establish a method for bio-fabricating human tissues and organs utilizing CollPlant Biotechnologies’ rh-Collagen-based bioinks and Stratasys Ltd’s P3 technology-based bioprinter, the two companies have signed a cooperative development and commercialization agreement. The first project focuses on making a solution for CollPlant’s program for regenerative breast implants that can be used on an industrial scale.

First US Surgeries Successfully Utilize 3D Printed PEEK Spinal Implants

First US Surgeries Successfully Utilize 3D Printed PEEK Spinal Implants

by Medical

In a medical 3D printing breakthrough, the first US surgeries featuring a revolutionary spinal implant made from Evonik‘s VESTAKEEP® i4 3DF PEEK filament biomaterial were conducted earlier this month. Developed by Curiteva, a US-based technology firm, the implant has been approved by the US Food and Drug Administration and is the first-ever 3D printed, fully interconnected porous polyether ether ketone (PEEK) implant of its kind for commercial use.

Regenerative Medicine strategy and tissue bioprinting plans announced by 3D Systems

Regenerative Medicine strategy and tissue bioprinting plans announced by 3D Systems

by Medical

3D Systems, a leading U.S. additive manufacturing company, has announced plans for a Regenerative Tissue Program (RPT). The strategic initiative aims to develop and commercialize bioprinted human tissue, building upon 3D Systems expertise in Healthcare from in-house products such as Virtual Surgical Planning (VSP) and recent acquisitions, including the $400M purchase of Volumetric Biotechnologies.